US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

The package revives President Donald Trump’s much-maligned Most Favored Nation rule but goes further into the private markets and beyond, leveraging the patent system, drug importation and more.

A bold move by US President Donald Trump to slash the cost of prescription drugs in America has sent shockwaves through the ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...

Trump’s drug pricing order sparks global pharma sell-off as industry warns of stifled innovation and revenue loss in key US ...

Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, ...

Eli Lilly’s expanding US production and advancing pipeline offset near-term headwinds and support bullish conviction. Read ...

Eli Lilly's stock suffered a nearly 12% loss in markets Thursday despite strong earnings, in what analysts say is an ...

Eli Lilly stock might still have a lot of upside to it, despite increasing competition among weight-loss drugs. Rival Novo ...